Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Shares Outstanding (2016 - 2025)

HealthLynked (HLYK) has disclosed Shares Outstanding for 10 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 3.56% to $2.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.8 million, a 3.56% increase, with the full-year FY2024 number at $281.9 million, up 2.17% from a year prior.
  • Shares Outstanding was $2.8 million for Q3 2025 at HealthLynked, up from $2.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $281.9 million in Q2 2024 to a low of $806828.0 in Q3 2021.
  • A 5-year average of $111.3 million and a median of $2.8 million in 2024 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: surged 9530.17% in 2023, then tumbled 98.96% in 2024.
  • HealthLynked's Shares Outstanding stood at $237.9 million in 2021, then rose by 7.59% to $255.9 million in 2022, then tumbled by 98.93% to $2.8 million in 2023, then rose by 2.61% to $2.8 million in 2024, then increased by 0.92% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Shares Outstanding are $2.8 million (Q3 2025), $2.8 million (Q2 2025), and $2.8 million (Q1 2025).